Atara Biotherapeutics Inc. named Utpal Koppikar to the position of CFO.
Koppikar most recently served at Gilead Sciences Inc. as vice president for corporate and operations finance.
South San Francisco, Calif.-based Atara Biotherapeutics develops allogeneic T-cell immunotherapy to treat cancer, autoimmune and viral diseases.
